Context Therapeutics Reports Third Quarter 2023 Operating and Financial Results

December 15, 2023

https://www.globenewswire.com/news-release/2023/11/09/2777887/0/en/Context-Therapeutics-Reports-Third-Quarter-2023-Operating-and-Financial-Results.html

CTIM-76 IND filing on track for late Q1 2024

Cash and cash equivalents of $21.7 million as of September 30, 2023

Company expects its cash and cash equivalents will continue to fund operations into late 2024

Read more at globenewswire.com

Related news for (CNTX)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.